Xtant Medical Holdings Inc (XTNT)

[ash111]

That's History. Xtant Medical reports preliminary Q4 and FY16 results:Xtant Medical Holdings (NYSEMKT:XTNT) expects Q4 revenue to be at least $24.5M (+10% Y/Y) vs. a consensus of $24.3M. Adjusted EBITDA is estimated to be at least $1.25M vs. a loss of $0.35M in the Q415.

Full year 2016, the Company has estimated that its sales will be at least $90.0M which represents 4.1% year on year growth. Adjusted EBITDA is estimated to be at least $2.2M vs. a loss of $335 for the FY15.

Reiterated 2017 Revenue guidance of between $98 - $102M.

Reiterated 2017 Adjusted EBITDA guidance of between $7.7 - $9.2M.

Market Value $6,584,744 a/o Jan 17, 2017
Fully diluted market cap is only $12.5.

2 FDA Clearances recently- https://www.networknewswire.com/two-fda-clearances-less-month-top-analysts-watching-xtant-medical-xtnt/

A strong ownership Including Goldman the Largest institutional here $124,212,000 Portfolio Q32016. http://www.thefoundersdaily.com/goldman-capital-management-inc-buys-600386-stake-in-xtant-medical-holdings-inc-xtnt/695041/

A Strong Buy consensus of $2.83 https://www.mideasttime.com/xtant-medical-holdings-inc-xtnt-given-average-recommendation-of-strong-buy-by-analysts/1482391.html

her day will come.